Tokai Pharmaceuticals Lands $22,000,000 Series D Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=03837a8c-060e-4fd9-9d12-520740733417&Preview=1 -
Date
5/8/2009 -
Company Name
Tokai Pharmaceuticals -
Mailing Address
One Broadway, 11th floor Cambridge , MA 02142 -
Company Description
The company develops biopharmaceutical products that focus on endocrine treatment. -
Website
http://www.tokaipharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$22,000,000 -
Transaction Round
Series D -
Proceeds Purposes
Proceeds from the financing will be used to advance Tokai’s lead development candidate, TOK-001, into the clinic for the treatment of advanced prostate cancer. -
M&A Terms
-
Venture Investor
Novartis Venture Fund -
Venture Investor
Apple Tree Partners
